Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chunlan Zhuang"'
Autor:
Xingcheng Huang, Xiaoxiang Zheng, Lin Chen, Chunlan Zhuang, Changlin Yang, Xia Zang, Yijun Wang, Hanmin Jiang, Xiaomeng Huang, Qiang Yan, Zimin Tang, Yingying Su, Zizheng Zheng, Ting Wu, Xuefeng Zhang, Yue Huang, Shoujie Huang, Fengcai Zhu, Jun Zhang, Ningshao Xia
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Hepatitis E virus (HEV) is an important cause of acute hepatitis, however, is highly neglected and largely underreported. This study aimed to describe the detailed epidemiology of hepatitis E (HE) through a 10-year surveillance. A community-based act
Externí odkaz:
https://doaj.org/article/d1f316324be145d988080ccc01f7e1ea
Autor:
Liang Zhang, Yao Jiang, Jinhang He, Junyu Chen, Ruoyao Qi, Lunzhi Yuan, Tiange Shao, Hui Zhao, Congjie Chen, Yaode Chen, Xijing Wang, Xing Lei, Qingxiang Gao, Chunlan Zhuang, Ming Zhou, Jian Ma, Wei Liu, Man Yang, Rao Fu, Yangtao Wu, Feng Chen, Hualong Xiong, Meifeng Nie, Yiyi Chen, Kun Wu, Mujin Fang, Yingbin Wang, Zizheng Zheng, Shoujie Huang, Shengxiang Ge, Shih Chin Cheng, Huachen Zhu, Tong Cheng, Quan Yuan, Ting Wu, Jun Zhang, Yixin Chen, Tianying Zhang, Changgui Li, Hai Qi, Yi Guan, Ningshao Xia
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants and “anatomical escape” characteristics threaten the effectiveness of current coronavirus disease 2019 (COVID-19) vaccines. There is an urgent need to
Externí odkaz:
https://doaj.org/article/e3960e4523224e0888469ff72727bae6
Autor:
Guohua Zhong, Chunlan Zhuang, Xiaowen Hu, Qi Chen, Zhaofeng Bi, Xinhua Jia, Siying Peng, Yufei Li, Yue Huang, Qiufen Zhang, Ying Hong, Youlin Qiao, Yingying Su, Huirong Pan, Ting Wu, Lihui Wei, Shoujie Huang, Jun Zhang, Ningshao Xia
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTSpecial attention has been paid to Hepatitis E (HE) prophylaxis for pregnant women due to poor prognosis of HE in this population. We conducted a post-hoc analysis based on the randomized, double-blind, HE vaccine (Hecolin)-controlled phase 3
Externí odkaz:
https://doaj.org/article/acf452cf809b492f9f8862c9a34da8e4
Autor:
Qi Chen, Kongxin Zhu, Xiaohui Liu, Chunlan Zhuang, Xingcheng Huang, Yue Huang, Xingmei Yao, Jiali Quan, Hongyan Lin, Shoujie Huang, Yingying Su, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
Emerging Microbes and Infections, Vol 0, Iss 0, Pp 1-44 (2022)
The specific antibodies induced by SARS-CoV-2 infection may provide protection against a subsequent infection. However, the efficacy and duration of protection provided by naturally acquired immunity against subsequent SARS-CoV-2 infection remain con
Externí odkaz:
https://doaj.org/article/f3ba627eed5f4765963940d2ec87dfdd
Autor:
Yue Huang, Tingdong Li, Huan Yu, Jiabao Tang, Qiaoqiao Song, Xiaoyi Guo, Han Wang, Caihong Li, Jiangding Wang, Caihong Liang, Xingmei Yao, Lingxian Qiu, Chunlan Zhuang, Zhaofeng Bi, Yingying Su, Ting Wu, Shengxiang Ge, Jun Zhang
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1824-1831 (2021)
Background Congenital human cytomegalovirus (CMV) infection remains largely unrecognized and underemphasized in medical practice. This study aimed to describe the maternal CMV seroprevalence rate in early gestation and congenital CMV infection in a C
Externí odkaz:
https://doaj.org/article/f41ee8185b3047ea80e63d509724675d
Autor:
Chunlan Zhuang, Xiaohui Liu, Qi Chen, Yuxin Sun, Yingying Su, Shoujie Huang, Ting Wu, Ningshao Xia
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
The coronavirus disease 2019 (COVID-19) vaccines have very successfully decreased the disease risk as we know; some key information remains unknown due to the short development history and the lack of long-term follow-up studies in vaccinated populat
Externí odkaz:
https://doaj.org/article/51fc801cbdb3491883d16e822dc8ea89
Autor:
Ningshao Xia, Fengcai Zhu, Shou-Jie Huang, Xiaohui Liu, Qi Chen, Chunlan Zhuang, Jinle Han, Anjuli Jaen, Thai Hung Do, Jonathan Peter, Alexander Dorado, Louie Tirador, Gelza Zabat, Ralph Villalobos, Gemalyn Gueco, Lauren Botha, Shirley Pertuz, Jiaxiang Tan, Kongxin Zhu, Jiali Quan, Hongyan Lin, Yue Huang, Jizong Jia, Xiafei Chu, Junyu Chen, Yixin Chen, Tianying Zhang, Ying-Ying Su, Changgui Li, Xiangzhong Ye, Ting Wu, Jun Zhang
The live-attenuated influenza virus vector-based intranasal vaccine (dNS1-RBD, Pneucolin®) is the world’s first COVID-19 mucosal vaccine to enter human trials, and has been issued for emergency use authorization in China. Here, we report safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372819dd5e0f712e8b0acab3751924bd
https://doi.org/10.21203/rs.3.rs-2407050/v1
https://doi.org/10.21203/rs.3.rs-2407050/v1
Autor:
Liang Zhang, Yao Jiang, Jinhang He, Junyu Chen, Ruoyao Qi, Lunzhi Yuan, Tiange Shao, Congjie Chen, Yaode Chen, Xijing Wang, Xing Lei, Qingxiang Gao, Chunlan Zhuang, Ming Zhou, Jian Ma, Wei Liu, Man Yang, Rao Fu, Yangtao Wu, Feng Chen, Hualong Xiong, Meifeng Nie, Yiyi Chen, Kun Wu, Mujing Fang, Yingbin Wang, Zizheng Zheng, Shoujie Huang, Shengxiang Ge, Shih Chin Cheng, Huachen Zhu, Tong Cheng, Quan Yuan, Ting Wu, Jun Zhang, Yixin Chen, Tianying Zhang, Hai Qi, Yi Guan, Ningshao Xia
The emergence of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) variants and “anatomical escape” characteristics threaten the effectiveness of current coronavirus disease (COVID-19) vaccines. There is an urgent need to understand th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d7d56365b6fa20aa81fe0efa214cb8e
https://doi.org/10.1101/2022.10.03.510566
https://doi.org/10.1101/2022.10.03.510566
Autor:
Qi Chen, Kongxin Zhu, Xiaohui Liu, Chunlan Zhuang, Xingcheng Huang, Yue Huang, Xingmei Yao, Jiali Quan, Hongyan Lin, Shoujie Huang, Yingying Su, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
Emerging microbesinfections. 11(1)
The specific antibodies induced by SARS-CoV-2 infection may provide protection against a subsequent infection. However, the efficacy and duration of protection provided by naturally acquired immunity against subsequent SARS-CoV-2 infection remain con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e906b9323783e94c796471902ad5688
https://pubmed.ncbi.nlm.nih.gov/35195494
https://pubmed.ncbi.nlm.nih.gov/35195494
Autor:
Junyu Chen, Pui Wang, Lunzhi Yuan, Liang Zhang, Limin Zhang, Hui Zhao, Congjie Chen, Xijing Wang, Jinle Han, Yaode Chen, Jizong Jia, Zhen Lu, Junping Hong, Zicen Lu, Qian Wang, Rirong Chen, Ruoyao Qi, Jian Ma, Min Zhou, Huan Yu, Chunlan Zhuang, Xiaohui Liu, Qiangyuan Han, Guosong Wang, Yingying Su, Quan Yuan, Tong Cheng, Ting Wu, Xiangzhong Ye, Tianying Zhang, Changgui Li, Jun Zhang, Huachen Zhu, Yixin Chen, Honglin Chen, Ningshao Xia
Publikováno v:
Science bulletin. 67(13)
Remarkable progress has been made in developing intramuscular vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with respect to eliciting local immunity in the respiratory tract, which is the pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1d4fd67c4bfcb288d09c12f6235a4c
https://pubmed.ncbi.nlm.nih.gov/35637645
https://pubmed.ncbi.nlm.nih.gov/35637645